Hypopituitarism Diagnostics Market
Number of pages: 100 | Report Format: PDF | Published date: February 28, 2023
Historical Years – 2020 | Base Year – 2021 | Forecasted Years – 2022-2030
|
Report Attribute |
Details |
|
Market Size Value in 2021 |
US$ 258.11 million |
|
Revenue Forecast in 2030 |
US$ 362.4 million |
|
CAGR |
5.8% |
|
Base Year for Estimation |
2022 |
|
Forecast period |
2022-2030 |
|
Historical Year |
2020 |
|
Segments Covered |
Type, Test Type, End-User, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, and the Rest of the World (RoW) |
According to the deep-dive market assessment study by Growth Plus Reports, the global hypopituitarism diagnostics market was valued at US$ 258.11 million in 2021 and is expected to register a revenue CAGR of 5.8% to reach US$ 362.4 million by 2030.
Hypopituitarism Diagnostics Market Fundamentals
Hypopituitarism is a rare hormonal disorder caused by a deficiency of pituitary hormones, such as growth hormones, thyroid hormones, and sex hormones. Pituitary hormones control vital functions of the body, including metabolism, growth, development, and reproduction. Hypopituitarism can be caused due to tumors in pituitary glands, radiation treatment, surgery in the pituitary, and severe blood loss during childbirth. Apart from this, hypopituitarism can also be caused by abnormal development of the pituitary gland as a result of mutations in gene coding, which regulates pituitary development.
Primary hypopituitarism, secondary hypopituitarism, and idiopathic hypopituitarism are three types of hypopituitarism based on how the pituitary gland and its hormones are affected. Primary hypopituitarism is caused by damage to the pituitary glands. Secondary hypopituitarism is caused by damage to the hypothalamus. And idiopathic hypopituitarism is caused by hypothalamic injury or abnormalities. The pituitary stalk connects the pituitary gland to the hypothalamus. Issues with the hypothalamus might cause hypopituitarism as it instructs the pituitary gland to release specific hormones.
[8678856]
Hypopituitarism Diagnostics Market Dynamics
A pituitary adenoma is one of the common causes of hypopituitarism. Pituitary adenoma can cause pressure on the pituitary gland and blocks blood flow. These adenomas cause an imbalance of hormones affecting many body functions. Mostly, in the younger age group, pituitary adenoma is the common cause of hypopituitarism. Adenomas, when treated with surgeries or radiation therapy, can result in hypopituitarism. For instance, according to Cleaveland Clinic, about 60% of patients with pituitary adenomas experience hypopituitarism after surgery and/or radiation therapy.
Diagnosis of hypopituitarism is important in pregnant women as it can help to prevent complications during pregnancy and childbirth. Pituitary hormones are important for the development of the baby’s brain and nervous system. If the pituitary gland is not producing sufficient of these hormones, the mother can develop complications, such as high blood pressure, gestational diabetes, and anemia. These complications can put the mother and baby at risk during pregnancy and childbirth. Therefore, pregnant women need to be screened for hypopituitarism so that they can receive treatment if needed.
However, in rural areas of developing nations, many individuals are deprived of proper diagnosis due to a lack of healthcare accessibility. Thus, this factor can hamper the development of the global hypopituitarism diagnostics market.
Hypopituitarism Diagnostics Market Ecosystem
The global hypopituitarism diagnostics market has been analyzed from four perspectives: type, test type, end-user, and region.
Hypopituitarism Diagnostics Market by Type
Based on type, the global hypopituitarism diagnostics market has been segmented into isolated pituitary deficiency, multiple pituitary hormone deficiency, and panhypopituitarism.
Isolated pituitary deficiency is a rare endocrine disorder that occurs when one hormone produced by the pituitary gland fails to release. This can lead to a wide range of symptoms, including infertility, delayed or absence of puberty, growth failure, and decreased muscle mass. Additionally, this condition can cause imbalances in other hormones, leading to problems with metabolism, thyroid function, and adrenal function. Treatment for this condition typically involves hormone replacement therapy, which is a long-term treatment option. Surgery may also be an option in some cases. With proper treatment, many of the symptoms associated with this condition can be managed, and quality of life can be improved. Multiple pituitary hormone deficiency occurs when more than one pituitary hormone is deficient. It can occur as a result of acquired injuries in the hypothalamic-pituitary region, such as a tumor, surgery, trauma, or irradiation. They can also be idiopathic or the result of hereditary disorders.
Panhypopituitarism is a disorder characterized by the insufficient or no synthesis of anterior pituitary hormones. It is typically the result of numerous issues that impact the pituitary gland, reducing or destroying its function or interfering with the hypothalamic release of the various pituitary-releasing hormones.
Hypopituitarism Diagnostics Market by Test Type
[9784678]
Based on test type, the global hypopituitarism diagnostics market has been segmented into hormone stimulation tests, MRI or CT scan, insulin tolerance tests, visual tests, and others.
The MRI or CT scan segment dominates the hypopituitarism diagnostics market. MRI is a powerful diagnostic practice for diagnosing hypopituitarism, due to its ability to produce high-resolution, three-dimensional images of the pituitary gland. These images can be used to detect changes in the pituitary gland, including the size, shape, and function of the gland. MRI can also detect tumors, cysts, and other abnormalities in the pituitary gland. Additionally, MRI can be utilized in the detection of changes in the surrounding structures, such as the hypothalamus and optic chiasm, which can help to identify secondary causes of hypopituitarism. MRI is also non-invasive and does not require any radiation, making it a safe and highly effective diagnostic tool.
Hypopituitarism Diagnostics Market by End User
Based on end user, the global hypopituitarism diagnostics market has been segmented into hospitals, specialty clinics, and academic research institutes.
The hospitals segment accounted for the largest market revenue share in 2021. Hospitals are better equipped to diagnose hypopituitarism as they have access to more specialized tests and equipment. Hospitals can help with more accurate diagnoses. Additionally, they can provide more comprehensive treatments for hypopituitarism, such as hormone replacement therapy and other treatments that may not be available to a primary care physician. Moreover, hospitals can provide more support to those with hypopituitarism, such as counseling and support groups.
Hypopituitarism Diagnostics Market by Region
Regionally, the global hypopituitarism diagnostics market has been segmented into North America, Europe, Asia Pacific, and the rest of the world.
North America dominated the global hypopituitarism diagnostics market with the largest revenue share in 2021. A key factor supporting the growth of the global hypopituitarism diagnostics market is the increasing prevalence of hypopituitarism. Deficiency of somatotropin hormone is the most common pituitary hormone deficiency in North America. According to the National Center for Biotechnology Information (NCBI), every 4,000 to 10,000 people have somatotropin deficiency in 2021. Moreover, growth hormone (GH) depletion is a frequent pituitary hormone shortage (CCS) in cancer survivors, mostly children. This increasing prevalence makes hypopituitarism diagnostics very necessary. Moreover, the presence of many startup companies in the region offering various new diagnostics services is a potential factor influencing the development of the hypopituitarism diagnostics market. For instance, Eli is a Canadian FemTech startup that is creating an at-home gadget that can record daily hormone saliva as well as an app that is intended to deliver insights customized to the user’s profile. The startup creates an at-home gadget that measures hormone fluctuations as well as an app that provides women with the knowledge they need to make their own health decisions daily.
Asia Pacific is expected to show high growth opportunities during the forecast years, owing to increased healthcare standards. Moreover, rising number of hospitals is also anticipated to fuel the hypopituitarism diagnostics market revenue growth in the region. Moreover, the Asia Pacific market is driven by an increase in research activity aimed at improving disease detection and treatment.
Hypopituitarism Diagnostics Market Competitive Landscape
The prominent players operating in the global hypopituitarism diagnostics market are:
The increase in the prevalence of hypopituitarism, growth in governments support, and rise in the number of research and development activities are propelling the global hypopituitarism diagnostics market.
Bio Rad Laboratories, Inc., Abbott Laboratories, BioMerieux SA, and Danaher Corporation are among the top market players.
Many individuals from rural areas of developing nations are deprived of proper diagnosis due to a lack of healthcare accessibility. This factor can hamper the revenue growth of the global hypopituitarism diagnostics market.
The global hypopituitarism diagnostics market is expected to register a revenue CAGR of 5.8 % during the forecast period from 2022 to 2030.
The MRI segment accounted for the majority of the market revenue share in 2021.
*Insights on financial performance are subject to the availability of information in the public domain